Evidence map›Paper›PMID 35000046›Full record

ReviewCell and tissue banking2022

From 3D printing to 3D bioprinting: the material properties of polymeric material and its derived bioink for achieving tissue specific architectures.

Nihal Engin Vrana, Sharda Gupta, Kunal Mitra, Albert A Rizvanov, Valeriya V Solovyeva, Ezgi Antmen, Majid Salehi, Arian Ehterami, Lea Pourchet, Julien Barthes and 5 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cell and tissue banking, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Nihal Engin VranaSpartha Medical, Strasbourg, France. evrana@sparthamedical.eu.
Sharda GuptaNational Institute of Technology, Raipur, India.
Kunal MitraFlorida Institute of Technology, Melbourne, USA.
Albert A RizvanovKazan Federal University, Kazan, Russia.
Valeriya V SolovyevaKazan Federal University, Kazan, Russia.
Ezgi AntmenCenter of Excellence in Biomaterials and Tissue Engineering, BIOMATEN, Middle East Technical University (METU), Ankara, Turkey.
Majid SalehiDepartment of Tissue Engineering, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
Arian EhteramiDepartment of Mechanical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Lea PourchetUMR 1121, Biomaterials and Bioengineering, INSERM, Strasbourg, France.
Julien BarthesUMR 1121, Biomaterials and Bioengineering, INSERM, Strasbourg, France.
Christophe A MarquetteUniversité Lyon 1 - CNRS 5246 ICBMS, Lyon Cedex, France.
Magnus von UngeAkershus University Hospital and University of Oslo, Oslo, Norway.
Chi-Yun WangDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
Po-Liang LaiDepartment of Orthopedic Surgery, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
Arindam BitNational Institute of Technology, Raipur, India. arinbit.bme@nitrr.ac.in.ORCID http://orcid.org/0000-0003-4738-8324

Funding

Department of Science and Technology, Ministry of Science and Technology INT/RUS/RFBR/P-332Horizon 2020 760921Science and Engineering Research Board ECR/2017/001115
6 · The paper itself

Abstract

The application of 3D printing technologies fields for biological tissues, organs, and cells in the context of medical and biotechnology applications requires a significant amount of innovation in a narrow printability range. 3D bioprinting is one such way of addressing critical design challenges in tissue engineering. In a more general sense, 3D printing has become essential in customized implant designing, faithful reproduction of microenvironmental niches, sustainable development of implants, in the capacity to address issues of effective cellular integration, and long-term stability of the cellular constructs in tissue engineering. This review covers various aspects of 3D bioprinting, describes the current state-of-the-art solutions for all aforementioned critical issues, and includes various illustrative representations of technologies supporting the development of phases of 3D bioprinting. It also demonstrates several bio-inks and their properties crucial for being used for 3D printing applications. The review focus on bringing together different examples and current trends in tissue engineering applications, including bone, cartilage, muscles, neuron, skin, esophagus, trachea, tympanic membrane, cornea, blood vessel, immune system, and tumor models utilizing 3D printing technology and to provide an outlook of the future potentials and barriers.

Indexed as

BioprintingBone and BonesInkPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsBioprintingCell encapsulationIn-vitro techniquePerfusionRheologyTissue engineering

Identifiers

PMID35000046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.